Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07121114) titled 'CAPTIVATE India - A Study to Assess the Prevalence of Cardiovascular Disease (CVD) in Individuals With Type 2 Diabetes Mellitus (T2DM) in India' on Aug. 7.
Study Type: Observational
Primary Sponsor: Novo Nordisk A/S
Condition:
Type 2 Diabetes Mellitus
Intervention:
Other: No treatment given
Recruitment Status: Not recruiting
Date of First Enrollment: April 9, 2025
Target Sample Size: 1500
Countries of Recruitment:
India
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07121114
Published by HT Digital Content Services with permission from Health Daily Digest....